KZIA Kazia Therapeutics announces the filing of provisional patent for novel strategy, supported by preclinical data, to prevent metastatic
KZIA Kazia Therapeutics announces the filing of provisional patent for novel strategy, supported by preclinical data, to prevent metastatic recurrence in triple-negative breast cancer
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.